| Literature DB >> 31447507 |
Wondim Getnet1, Tesfaye Kebede1, Asfaw Atinafu1, Amir Sultan2.
Abstract
BACKGROUND: The aim of this study was to assess the role of transabdominal ultrasonography in characterizing and determining the etiology of ascites in comparison with laboratory ascitic fluid analysis and other methods used to establish the final diagnosis.Entities:
Keywords: SAAG; ascites characterization; ascites etiology; disease categories; ultrasound
Mesh:
Year: 2019 PMID: 31447507 PMCID: PMC6689719 DOI: 10.4314/ejhs.v29i3.11
Source DB: PubMed Journal: Ethiop J Health Sci ISSN: 1029-1857
Specific pathologies under each category with their frequency in 61 patients at TASH, 2017
| Frequency | Percent | |
| Benign cause=16 (26.2%) | ||
| CLD±PVT | 9 | 14.8 |
| PVT+BCS | 3 | 4.9 |
| Cardiac | 3 | 4.9 |
| Renal | 1 | 1.6 |
| Inflammatory=7 (9.8%) | ||
| Tuberculosis peritonitis | 5 | 8.2 |
| Pyogenic peritonitis | 1 | 1.6 |
| Malignant cause=20 (32.8%) | ||
| Ovarian cancer | 10 | 16.4 |
| Gastric cancer | 2 | 3.3 |
| GB cancer | 2 | 3.3 |
| Lymphoma | 2 | 3.3 |
| Others | 4 | 6.6 |
| Mixed causes=17 (27.9) | ||
| CLD+HCC ±PVT or BCS | 10 | 16.4 |
| Crohn's disease + hypoproteinemia | 2 | 3.3 |
| Tuberculous peritonitis + hypoproteinemia | 2 | 3.3 |
| Hematological malignancy + adult malnutrition | 1 | 1.6 |
| Pancreatic cancer +cardiac | 1 | 1.6 |
| Colonic cancer + hypoproteinemia | 1 | 1.6 |
| Indeterminate causes (3.3%) | 2 | 3.3 |
| Grand total | 61 |
CLD=chronic liver disease; PVT-portal vein thrombosis; BCS-Budd Chiari syndrome; HCC-hepatocellular carcinoma
Crosstabulation of sonographically determined ascitic pattern with disease categories in 61 patients at TASH, 2017
| US determined ascites pattern | P.value | ||||
| Transudate | Exudate | ||||
| Disease | Benign | 16 | 0 | 16 | |
| Malignant | 1 | 19 | 20 | ||
| Inflammatory Mixed | 1 11 | 5 6 | 6 17 | 0.000 | |
| Indeterminate | 2 | 0 | 2 | ||
| Total | 31 | 30 | 61 | ||
Crosstabulation of SAAG determined ascitic pattern with disease categories in 61 patients, at TASH, 2017
| SAAG determined ascites | P. value | ||||
| Transudate | Exudate | Total | |||
| Disease | Benign | 15 | 1 | 16 | |
| Malignant | 6 | 14 | 20 | ||
| Inflammatory | 2 | 4 | 6 | 0.000 | |
| Mixed | 16 | 1 | 17 | ||
| Indeterminate | 2 | 0 | 2 | ||
| Total | 41 | 20 | 61 | ||
Cross tabulation between disease categories and ascitic volume grading in 61 patients at TASH, 2017
| Graded ascitic volume | ||||
| Disease | Grade 0–2 | Grade 3–4 | Total | P value |
| Benign | 8 (50%) | 8 (50%) | 16 (100%) | |
| Malignant | 9 (45%) | 11 (55%) | 20 (100%) | |
| Inflammatory | 5 (83.3%) | 1 (16.7%) | 6 (100%) | 0.573 |
| Mixed | 8 (47%) | 9 (53%) | 17(100%) | |
| Indeterminate | 1 (50%) | 1 (50%) | 2 (100%) | |
Crosstabulation of sonographically determined ascites pattern with GB wall thickening in 61 patients at TASH, 2017
| GB wall thickening | |||||
| No | Yes | Total | P value | ||
| US determined ascites | Transudate | 9 (29.0%) | 22(71.0%) | 31(100.0%) | 0.000 |
| Exudate | 27 | 3 (10.0%) | 30(100.0%) | ||
| Total | 36(59.0%) | 25(41.0%) | 61(100.0%) | ||